SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cyberonics (cybx) epilepsy therapy recommonded -- Ignore unavailable to you. Want to Upgrade?


To: Trio who wrote (407)4/20/1999 10:16:00 PM
From: KAF  Respond to of 471
 
Contact their web site...they are very helpful with reimbursement issues. Trend is changing as far as drug therapy for epilepsy, trending away from toxic dose regimens.

Stock rose up in anticipation and then dropped on the news of FDA approval as many IPO's do. This is the alternative therapy to drugs or lobectomy, especially for those whose epilepsy foci are not localized.